This Article Full Text Full Text (PDF) All Versions of this Article: 24/11/2143    most recent 01.ATV.0000145607.03879.e0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nobuhiko, A. Articles by Kon, V. Search for Related Content PubMed PubMed Citation Articles by Nobuhiko, A. Articles by Kon, V.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2143.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Angiotensin II Amplifies Macrophage-Driven Atherosclerosis

Ayabe Nobuhiko; Eisuke Suganuma; Vladimir R. Babaev; Agnes Fogo; Larry L. Swift; MacRae F. Linton; Sergio Fazio; Iekuni Ichikawa; Valentina Kon

From the Departments of Pediatrics and Medicine and Pathology, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Valentina Kon, MD, Vanderbilt University Medical Center, Nashville, TN 37232-2584. E-mail valentina.kon{at}vanderbilt.edu

Objective— We evaluated the role of angiotensin II (AII) in a marrow-derived macrophage-driven model of atherosclerosis.

Methods and Results— Eight-week-old C57BL/6 wild-type mice were reconstituted with bone marrow harvested from apolipoprotein E-deficient (apoE–/– apoE+/+) or wild-type for apoE gene (apoE+/+ apoE+/+) mice. At 20 weeks, mice were exposed to either AII (1000 ng/kg per minute subcutaneously) or saline for 2 weeks. Animals did not differ in body weight, blood pressure, cholesterol/triglycerides, or peripheral blood monocyte counts. ApoE–/– apoE+/+ mice exposed to AII had 3-fold greater atherosclerotic area than saline-treated apoE–/– apoE+/+ mice. By contrast, AII did not affect atherosclerosis in apoE+/+ apoE+/+ mice. Macrophage-positive areas were increased by AII in mice reconstituted with either apoE-deficient or apoE-competent marrow. AII also significantly increased fragmentation of elastin laminae in both apoE–/– apoE+/+ and apoE+/+ apoE+/+ mice. In vitro, AII caused greater increase in monocyte chemoattractant protein-1–stimulated migration of macrophages harvested from AII-infused versus saline-infused mice.

Conclusions— The current studies reveal that AII has both initiating and sustaining proatherogenic effects. By promoting macrophage migration into the vascular intima, AII is pivotal in initiating atherosclerosis; by promoting elastin breaks, a novel mechanism implicated in migration and proliferation of smooth muscle cells, AII may be pivotal in subsequent development and expansion of atherosclerotic lesion.

Wild-type mice reconstituted with bone marrow from apolipoprotein E-deficient mice (apoE–/– apoE+/+) exposed to angiotensin II (AII) had 3-times greater atherosclerosis than mice reconstituted with wild-type marrow (apoE+/+ apoE+/+). AII increased macrophage-positive areas and elastin fragmentation in both groups. AII promotes macrophage migration to initiate atherosclerosis and elastin breaks that expands atherosclerosis.

Key Words: atherosclerosis • angiotensin II • macrophage

This article has been cited by other articles:

				J. B. Morris, A. R. Olzinski, and B. M. Jucker Patterns of USPIO Deposition in Murine Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): e158 - e159. [Full Text] [PDF]

				J. B. Morris, A. R. Olzinski, R. E. Bernard, K. Aravindhan, R. C. Mirabile, R. Boyce, R. N. Willette, and B. M. Jucker p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis: MRI Assessment Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 265 - 271. [Abstract] [Full Text] [PDF]

				E. Suganuma, V. R. Babaev, M. Motojima, Y. Zuo, N. Ayabe, A. B. Fogo, I. Ichikawa, M. F. Linton, S. Fazio, and V. Kon Angiotensin Inhibition Decreases Progression of Advanced Atherosclerosis and Stabilizes Established Atherosclerotic Plaques J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2311 - 2319. [Abstract] [Full Text] [PDF]

				L. Yvan-Charvet, A. Bobard, P. Bossard, F. Massiera, X. Rousset, G. Ailhaud, M. Teboul, P. Ferre, G. Dagher, and A. Quignard-Boulange In Vivo Evidence for a Role of Adipose Tissue SR-BI in the Nutritional and Hormonal Regulation of Adiposity and Cholesterol Homeostasis Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1340 - 1345. [Abstract] [Full Text] [PDF]

				H. Chon, M. C. Verhaar, H. A. Koomans, J. A. Joles, and B. Braam Role of Circulating Karyocytes in the Initiation and Progression of Atherosclerosis Hypertension, May 1, 2006; 47(5): 803 - 810. [Abstract] [Full Text] [PDF]

				E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction J. Am. Soc. Nephrol., February 1, 2006; 17(2): 433 - 441. [Abstract] [Full Text] [PDF]